The majority of the 18 analysts covering Biomea Fusion have provided bullish ratings, indicating a positive outlook for the stock. The average price target of $45.72 suggests a significant upside potential from the current price of $24.415. This positive sentiment from analysts is likely to have a short-term positive impact on the stock price.